CITADEL ADVISORS LLC

Position in NNVC — Nanoviricides, Inc.

CIK 1423053 MIAMI, FL

Back to NNVC Full portfolio

Position in NNVC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

-$90,303 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

21 quarters on record

Common Shares in NNVC Over Time

Shares Held

Position Value (USD)

Derivatives in NNVC

reported options exposure · as of Mar 31, 2026

CallValue

$32,669

CallShares

35,900

PutValue

PutShares

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,784,241,435 across 374 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	2,182,571	$356,894,009
2	ONC	BeOne Medicines Ltd.	1,032,298	$306,561,536
3	BMRN	Biomarin Pharmaceutical Inc	4,512,634	$254,918,694
4	JAZZ	Jazz Pharmaceuticals plc	1,259,444	$238,097,887
5	MDGL	Madrigal Pharmaceuticals, Inc.	453,843	$237,573,195
6	BBIO	BridgeBio Pharma, Inc.	3,173,940	$235,696,783
7	TERN	Terns Pharmaceuticals, Inc.	3,218,810	$169,695,662
8	PTGX	Protagonist Therapeutics, Inc	1,551,900	$163,570,260

All Filings in NNVC

Export CSV

40 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,669	35,900	+42.5%	Call	Defined	2026-05-15
2025-12-31	$28,476	25,200	-68.5%	Call	Defined	2026-02-17
2025-12-31	$90,303	79,915	+376.8%	Shares	Defined	2026-02-17
2025-09-30	$23,968	16,761	-55.1%	Shares	Defined	2025-11-14
2025-09-30	$53,339	37,300	-13.1%	Call	Defined	2025-11-14
2025-06-30	$60,060	42,900	-15.7%	Call	Defined	2025-08-14
2025-03-31	$59,553	50,900	+50800.0%	Call	Defined	2025-05-15
2025-03-31	$117	100	-99.7%	Put	Defined	2025-05-15
2024-12-31	$42,328	29,600	+5820.0%	Call	Defined	2025-02-14
2024-12-31	$715	500	-97.6%	Put	Defined	2025-02-14
2024-09-30	$31,800	21,200	+63.1%	Call	Defined	2024-11-14
2024-09-30	$19,500	13,000	-39.5%	Put	Defined	2024-11-14
2024-03-31	$24,927	21,489	-11.2%	Shares	Defined	2024-05-15
2024-03-31	$28,072	24,200	+2320.0%	Call	Defined	2024-05-15
2023-12-31	$1,020	1,000	-95.9%	Put	Defined	2024-02-14
2023-12-31	$24,990	24,500	+45.7%	Call	Defined	2024-02-14
2023-12-31	$17,157	16,821	+21.0%	Shares	Defined	2024-02-14
2023-09-30	$18,626	13,900	+2680.0%	Call	Defined	2023-11-14
2023-09-30	$670	500	-88.1%	Put	Defined	2023-11-14
2023-03-31	$4,914	4,200	-72.4%	Call	Defined	2023-05-15
2023-03-31	$17,789	15,205	+484.8%	Shares	Defined	2023-05-15
2023-03-31	$3,042	2,600	-97.1%	Put	Defined	2023-05-15
2022-12-31	$97,915	88,212	+90.5%	Shares	Defined	2023-02-14
2022-12-31	$51,393	46,300	-82.2%	Put	Defined	2023-02-14
2022-12-31	$288,933	260,300	+625.3%	Call	Defined	2023-02-14
2022-09-30	$62,087	35,889	-86.8%	Shares	Defined	2022-11-14
2022-09-30	$470,560	272,000	+482.4%	Call	Defined	2022-11-14
2022-09-30	$80,791	46,700	+267.7%	Put	Defined	2022-11-14
2022-03-31	$26,543	12,700	+8.5%	Call	Defined	2022-05-16
2021-12-31	$43,524	11,700	-14.1%	Call	Defined	2022-02-14
2021-12-31	$50,647	13,615	-0.6%	Shares	Defined	2022-02-14
2021-09-30	$63,568	13,700	-66.7%	Put	Defined	2021-11-15
2021-09-30	$191,168	41,200	+14.8%	Call	Defined	2021-11-15
2021-06-30	$166,576	35,900	+79.5%	Call	Defined	2021-08-16
2021-03-31	$94,400	20,000	-34.1%	Call	Defined	2021-05-21
2021-03-31	$143,214	30,342	+41.1%	Shares	Defined	2021-05-21
2020-12-31	$61,705	21,500	-31.3%	Call	Defined	2021-02-16
2020-09-30	$120,192	31,300	+200.8%	Call	Defined	2020-11-16
2020-09-30	$39,951	10,404	-51.0%	Shares	Defined	2020-11-16
2020-03-31	$121,894	21,236	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.